Compounds for the prevention and treatment of cardiovascular disease

Details for Australian Patent Application No. 2010204106 (hide)

Owner Resverlogix Corp.

Inventors Hansen, C. Henrik

Agent Cullens

Pub. Number AU-A-2010204106

PCT Pub. Number WO2010/079431

Priority 61/143,276 08.01.09 US

Filing date 8 January 2010

Wipo publication date 15 July 2010

International Classifications

C07D 239/91 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 403/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

18 August 2011 PCT application entered the National Phase

  PCT publication WO2010/079431 Priority application(s): WO2010/079431

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010204110-Data stream storage system

2010204105-Modular DNA-binding domains and methods of use